Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis

Clinical and Vaccine Immunology

Volumn 19, Issue 1, 2012, Pages 23-29

  Magalhaes A ^a   Ferreira, K S ^b   Almeida, S R ^a   Nosanchuk, J D ^c   Travassos, L R ^b   Taborda, C P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN GP 43; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 14; PEPTIDE 10; PEPTIDE VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IN VITRO STUDY; LUNG INJURY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PATHOGEN LOAD; PRIORITY JOURNAL; SINGLE DRUG DOSE; SOUTH AMERICAN BLASTOMYCOSIS; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; FUNGAL VACCINES; GLYCOPROTEINS; LUNG; MALE; MICE; MICE, INBRED BALB C; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; VACCINATION; VACCINES, SUBUNIT;

EID: 84855715725     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05414-11     Document Type: Article

References (44)

1. Almeida SR, Lopes JD. 2001. The low efficiency of dendritic cells and macrophages from mice susceptible to Paracoccidioides brasiliensis in inducing a Th1 response. Braz. J. Med. Biol. Res. 34:529-537. (Pubitemid 33664484)
2. Amaral AC, et al. 2010. Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis. Br. J. Pharmacol. 159:1126-1132.
3. Austyn JM. 2000. Antigen-presenting cells. Experimental and clinical studies of dendritic cells. Am. J. Respir. Crit. Care Med. 162(Part 2):S146-S150.
4. Banchereau J, et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811. (Pubitemid 30365397)
5. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252. (Pubitemid 28155090)
6. Benard G. 2008. An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia 165:209-221. (Pubitemid 351585239)
7. Brummer E, Hanson LH, Restrepo A, Stevens DA. 1988. In vivo and in vitro activation of pulmonary macrophages by IFN-gamma for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis. J. Immunol. 140:2786-2789.
8. Buissa-Filho R, et al. 2008. The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus. Infect. Immun. 76:3321-3328.
9. Cano LE, et al. 1998. Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis. Infect. Immun. 66:800-806. (Pubitemid 28074230)
10. Castaneda E, Brummer E, Perlman AM, McEwen JG, Stevens DA. 1988. A culture medium for Paracoccidioides brasiliensis with high plating efficiency, and the effect of siderophores. J. Med. Vet. Mycol. 26:351-358. (Pubitemid 19098208)
11. Cisalpino PS, et al. 1996. Cloning, characterization, and epitope expression of the major diagnostic antigen of Paracoccidioides brasiliensis. J. Biol. Chem. 271:4553-4560. (Pubitemid 26070566)
12. de Camargo ZP. 2008. Serology of paracoccidioidomycosis. Mycopathologia 165:289-302.
13. Dionne SO, et al. 2006. Spherules derived from Coccidioides posadasii promote human dendritic cell maturation and activation. Infect. Immun. 74:2415-2422.
14. Eggert AA, et al. 1999. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59:3340-3345. (Pubitemid 29334488)
15. Gildea LA, Morris RE, Newman SL. 2001. Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J. Immunol. 166:1049-1056. (Pubitemid 32060262)
16. Holt PG, McMenamin C. 1989. Defense against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin. Exp. Allergy 19:255-262. (Pubitemid 19147909)
17. Huck SP, et al. 2008. Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+T cells against tumors. Cancer Immunol. Immunother. 57:63-71. (Pubitemid 350043649)
18. Inaba K, et al. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
19. Iwai LK, et al. 2003. In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals. Mol. Med. 9:209-219. (Pubitemid 38858175)
20. Kurita N, Oarada M, Miyaji M, Ito E. 2000. Effect of cytokines on antifungal activity of human polymorphonuclear leucocytes against yeast cells of Paracoccidioides brasiliensis. Med. Mycol. 38:177-182. (Pubitemid 30223734)
21. Kwon-Chung KJ, Tewari RP. 1987. Determination of viability of Histoplasma capsulatum yeast cells grown in vitro: comparison between dye and colony count methods. J. Med. Vet. Mycol. 25:107-114. (Pubitemid 17079993)
22. Lappin MB, et al. 1999. Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology 98:181-188. (Pubitemid 29487638)
23. Lutz MB, et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92. (Pubitemid 29096240)
24. Marques AF, et al. 2008. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis. Microb. Infec. 10:1251-1258.
25. Martin-Fontecha A, et al. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198:615-621. (Pubitemid 37040395)
26. Ministério da Saúde. 2005. Secretaria de Vigilância em Saúde. Departamento de Análise de Situação em Saúde. Saúde Brasil 2005: uma análise da situação de saúde no Brasil. Brasília (DF), Brazil.
27. Ministério da Saúde. 2009. Departamento de Informática do SUS-DATASUS. Arquivos eletrônicos dos dados do Sistema de Informações sobre Mortalidade-SIM. Base de dados 1996 a 2005. Brasília, Brazil. www.datasus.gov.br.
28. Moscardi-Bacchi M, Brummer E, Stevens DA. 1994. Support of Paracoccidioides brasiliensis multiplication by human monocytes or macrophages: inhibition by activated phagocytes. J. Med. Microbiol. 40: 159-164. (Pubitemid 24090927)
29. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63. (Pubitemid 14203433)
30. Okada N, et al. 2001. Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens. Br. J. Cancer 84:1564-1570. (Pubitemid 32579351)
31. Prado M, da Silva MB, Laurenti R, Travassos LR, Taborda CP. 2009. Mortality in Brazil of systemic mycosis as primary cause of death or in association with AIDS: a review from 1996 to 2006. Mem. Inst. Oswaldo Cruz 104:513-521.
32. Puccia R, McEwen JG, and Cisalpino PS. 2008. Diversity in Paracoccidioides brasiliensis. The PbGP43 gene as a genetic marker. Mycopathologia 165:275-287. (Pubitemid 351585235)
33. Puccia R, Schenkman S, Gorin PA, Travassos LR. 1986. Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect. Immun. 53:199-206. (Pubitemid 16084386)
34. Santambrogio L, Sato AK, Fischer FR, Dorf ME, Stern LJ. 1999. Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 96:15050-15055. (Pubitemid 30019763)
35. Shikanai-Yasuda MA, Telles Filho Q, Mendes RP, Colomboand AL, Moretti ML. 2006. Guidelines in paracoccidioidomycosis. Rev. Soc. Bras. Med. Trop. 39:297-310.
36. Shortman K, Liu YJ. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161. (Pubitemid 37336516)
37. Shortman K, Lahoud MH, Caminschi I. 2009. Improving vaccines by targeting antigens to dendritic cells. Exp. Mol. Med. 41:61-66.
38. Steinman RM, Witmer MD. 1978. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. U. S. A. 75:5132-5136. (Pubitemid 9046495)
39. Taborda CP, Juliano MA, Puccia R, Franco M, Travassos LR. 1998. Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect. Immun. 66:786-793. (Pubitemid 28074228)
40. Teixeira MM, et al. 2009. Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus. Mol. Phylogenet. Evol. 52:273-283.
41. Travassos LR, Taborda CP, Iwai LK, Cunha Neto E, Puccia R. 2004. The gp43 from Paracoccidioides brasiliensis: a major diagnostic antigen and vaccine candidate, p 279-296. In Domer JE, Kobayashi GS (ed), The Mycota XII human fungal pathogens. Springer-Verlag, Heildeberg, Germany.
42. Travassos LR, Rodrigues EG, Iwai LK, Taborda CP. 2008. Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy. Mycopathologia 165:341-352. (Pubitemid 351585236)
43. Travassos LR, Goldman G, Taborda CP, Puccia R. 2007. Insights in Paracoccidioides brasiliensis pathogenicity, p 241-265. In Kavanagh K (ed), New insights in medical mycology. Springer, Dordrecht, The Netherlands.
44. Uenotsuchi TS, et al. 2006. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Int. Immunol. 18:1637-1646.